"Integrative Omics Approaches for Leukemia Target Identification and Matched Therapeutic Intervention"

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Myeloid Leukemia, AcuteLeukemia, Acute Lymphoblastic
Interventions
BIOLOGICAL

Functional tests

Functional analyses will be performed on primary sample from each enrolled patient. Isolated blast cells are cultered and incubated with a specific library of drugs (175 drugs) at four different concentrations for 72 hours.

GENETIC

Next Generation Sequencing analysis

For each patient, sequencing analyses will be performed on blast cells (for somatic mutations) and on epithelial cells from buccal swab (for germline mutations)

BIOLOGICAL

Microvesicles analysis

Analyses on microvesicles isolated from both Bone Marrow samples and Peripheral Blood Samples will be performed to investigate the microenvironment of the disease.

Trial Locations (8)

29121

RECRUITING

Piacenza Hospital - AUSL Piacenza, Piacenza

40138

RECRUITING

A.O.U. Bologna, Bologna

42100

RECRUITING

A.O. Reggio Emilia, Reggio Emilia

43126

RECRUITING

AOU Parma, Parma

44124

RECRUITING

A.O.U. Ferrara, Ferrara

47014

RECRUITING

IRST-IRCCS Meldola, Meldola

47923

RECRUITING

Rimini Hospital-AUSL Romagna, Rimini

48121

RECRUITING

Ravenna Hospital - AUSL Romagna, Ravenna

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria di Parma

OTHER